2017
DOI: 10.1016/j.jaad.2017.02.051
|View full text |Cite
|
Sign up to set email alerts
|

Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…Faecal calprotectin is a useful screening tool for identifying patients most likely to need an endoscopy for IBDs. 7 Recently, Bissonnette et al 8 reported patients with active Ps (moderate to severe Ps), who never received a diagnosis of IBDs and or had a history of gastrointestinal symptoms, underwent capsule endoscopy to determine the prevalence of subclinical CD. Faecal calprotectin levels were measured at baseline and compared with capsule endoscopy findings to evaluate the potential of this biomarker as a screening tool for undiagnosed IBD in patients with Ps.…”
Section: Psoriasis/inflammatory Bowel Diseases: a Time To Solve The Lmentioning
confidence: 99%
“…Faecal calprotectin is a useful screening tool for identifying patients most likely to need an endoscopy for IBDs. 7 Recently, Bissonnette et al 8 reported patients with active Ps (moderate to severe Ps), who never received a diagnosis of IBDs and or had a history of gastrointestinal symptoms, underwent capsule endoscopy to determine the prevalence of subclinical CD. Faecal calprotectin levels were measured at baseline and compared with capsule endoscopy findings to evaluate the potential of this biomarker as a screening tool for undiagnosed IBD in patients with Ps.…”
Section: Psoriasis/inflammatory Bowel Diseases: a Time To Solve The Lmentioning
confidence: 99%
“…Having reviewed the articles already published (Table 1) on the subject, we found that earlier case reports had already demonstrated successful isotretinoin introduction in patients known to be allergic to peanut, accounting, in total, for 12 patients. [4][5][6][7][8][9] None of these patients experienced adverse allergic events. The investigations varied slightly from one case report to another, but overall, most patients underwent prick testing for peanut and isotretinoin.…”
mentioning
confidence: 99%